{"filing":{"accession_number":"0001437749-26-020967","cik":"0001831868","ticker":"ICUCW","company_name":"SeaStar Medical Holding Corp","form":"8-K","filing_date":"2026-06-17","report_date":null,"primary_document":"icu20260616_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1831868/000143774926020967/icu20260616_8k.htm"},"events":[{"id":11548,"run_id":10142,"accession_number":"0001437749-26-020967","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"SeaStar Medical held its annual meeting of shareholders on June 17, 2026, with stockholders voting on four proposals: election of Class I director John Neuman, approval of an amended 2022 Omnibus Incentive Plan increasing authorized shares from 207,046 to 896,546, ratification of WithumSmith+Brown, PC as independent auditor, and adjournment authority. All four proposals passed.","company_name":"SeaStar Medical Holding Corp","ticker":"ICUCW","filing_date":"2026-06-17","submitted_at":null,"items":[{"id":8155,"accession_number":"0001437749-26-020967","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The disclosure centers on shareholder approval of an amendment and restatement of the 2022 Omnibus Incentive Plan, which increases authorized shares for equity compensation from 207,046 to 896,546 shares. This is a material compensatory arrangement affecting the pool of equity available for executive and employee awards, fitting the exec_compensation category. While Item 5.07 results are also mentioned, the substantive disclosure in Item 5.02 addresses the equity plan amendment itself.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:09:21.513070+00:00","company_name":"","ticker":null,"filing_date":""},{"id":8156,"accession_number":"0001437749-26-020967","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from SeaStar Medical's annual meeting held June 17, 2026. The filing reports voting outcomes on four proposals: election of a Class I director (John Neuman), approval of an amended 2022 Omnibus Incentive Plan increasing authorized shares, ratification of WithumSmith+Brown, PC as independent auditor, and adjournment authority. All proposals passed. This is material as it documents stockholder approval of significant corporate actions including equity plan expansion and auditor ratification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:09:21.513070+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8155,"accession_number":"0001437749-26-020967","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The disclosure centers on shareholder approval of an amendment and restatement of the 2022 Omnibus Incentive Plan, which increases authorized shares for equity compensation from 207,046 to 896,546 shares. This is a material compensatory arrangement affecting the pool of equity available for executive and employee awards, fitting the exec_compensation category. While Item 5.07 results are also mentioned, the substantive disclosure in Item 5.02 addresses the equity plan amendment itself.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:09:21.513070+00:00","company_name":"SeaStar Medical Holding Corp","ticker":"ICUCW","filing_date":"2026-06-17"},{"id":8156,"accession_number":"0001437749-26-020967","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from SeaStar Medical's annual meeting held June 17, 2026. The filing reports voting outcomes on four proposals: election of a Class I director (John Neuman), approval of an amended 2022 Omnibus Incentive Plan increasing authorized shares, ratification of WithumSmith+Brown, PC as independent auditor, and adjournment authority. All proposals passed. This is material as it documents stockholder approval of significant corporate actions including equity plan expansion and auditor ratification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:09:21.513070+00:00","company_name":"SeaStar Medical Holding Corp","ticker":"ICUCW","filing_date":"2026-06-17"}]}